TCL Archive Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol March 5, 1999
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006